Menu

1 / 2

AbCellera Biologics Inc. (ABCL) Q1 2026 Earnings Call Transcript

Seeking Alpha·SA Transcripts·6 months ago
#rJMJNYXu
#source#chevron#alpha#officer#chief
Reading 0:00
15s threshold

AbCellera Biologics Inc. ( ABCL ) Q1 2026 Earnings Call May 11, 2026 5:00 PM EDT

Company Participants

Tryn Stimart - Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer

Carl L. Hansen - CEO, President & Chairperson

Sarah Noonberg - Chief Medical Officer

Andrew Booth - Chief Financial Officer

Conference Call Participants

Stephen Willey - Stifel, Nicolaus & Company, Incorporated, Research Division

Evan Seigerman - BMO Capital Markets Equity Research

Srikripa Devarakonda - Truist Securities, Inc., Research Division

Allison Bratzel - Piper Sandler & Co., Research Division

Brendan Smith - TD Cowen, Research Division

Debanjana Chatterjee - JonesTrading Institutional Services, LLC, Research Division

Steven Seedhouse - Cantor Fitzgerald & Co., Research Division

Presentation

Operator

Good afternoon, and welcome to AbCellera's Q1 2026 Business Update Conference Call. My name is Ben, and I will facilitate the audio portion of today's interactive broadcast.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.